《药学进展》杂志为 2 0 0 1年 2月国家药品监督管理局、国家工商行政管理局、国家新闻出版署等 3部门联合批准的第一批可以登载处方药广告的 1 64种医药专业媒体之一。《药学进展》拥有相对稳定的读者群 ,主要读者为从事药物研制开发、临床应用的医药界人士。因此 ,本刊除处方 Pharmaceutical Progress magazine was the first batch of 64 pharmaceutical professional media that can advertise prescription drug advertisements jointly approved by the State Drug Administration, State Administration for Industry and Commerce, and State Press and Publication Administration in February 2001 one. Pharmacopoeia has a relatively stable readership. The main readers are medical practitioners engaged in drug research and development and clinical application. Therefore, this publication except prescription